| Literature DB >> 31973603 |
Philip Brainin1, Sune Haahr-Pedersen1, Flemming Javier Olsen1, Anna Engell Holm1, Thomas Fritz-Hansen1, Thomas Jespersen2, Gunnar Gislason1, Tor Biering-Sørensen1,2.
Abstract
Background Early systolic lengthening (ESL) may occur in ischemic myocardial segments with reduced contractile force. We sought to evaluate the prognostic potential of ESL in patients with ST-segment-elevation myocardial infarction treated with primary percutaneous coronary intervention. Methods and Results We prospectively enrolled 373 patients with ST-segment-elevation myocardial infarction treated with primary percutaneous coronary intervention. All patients underwent a speckle tracking echocardiographic examination a median of 2 days (interquartile range, 1-3 days) after the percutaneous coronary intervention. We assessed a novel viability index, the ESL index, defined as follows: [-100×(peak positive systolic strain/peak negative strain in cardiac cycle)]. We also calculated ESL duration, defined as time from onset of QRS complex on the ECG to time of peak positive systolic strain. Both parameters were averaged from 18 myocardial segments. During a median follow-up of 5.3 years (interquartile range, 2.5-6.0 years), 145 (39%) experienced major adverse cardiovascular events, a composite of incident heart failure, new myocardial infarction, and all-cause mortality. The ESL index and ESL duration were significantly increased in culprit lesion areas (6.7±6.2% versus 5.0±4.1% and 43±33 ms versus 33±24 ms, respectively; P<0.001 for both). In Cox proportional hazard models, the ESL index (hazard ratio, 1.27 per 1% increase; 95% CI, 1.13-1.43; P<0.001) and ESL duration (hazard ratio, 1.49 per 1-ms increase; 95% CI, 1.15-1.92; P=0.002) yielded prognostic information on major adverse cardiovascular events. Both associations remained significant after adjusting for clinical, echocardiographic, and invasive confounders. Conclusions Assessment of ESL after primary percutaneous coronary intervention in patients with ST-segment-elevation myocardial infarction yields independent and significant prognostic information on the future risk of cardiovascular events.Entities:
Keywords: 2‐dimensional speckle tracking echocardiography; deformation; early systolic lengthening; echocardiography; myocardial infarction; revascularization
Mesh:
Year: 2020 PMID: 31973603 PMCID: PMC7033900 DOI: 10.1161/JAHA.119.013835
Source DB: PubMed Journal: J Am Heart Assoc ISSN: 2047-9980 Impact factor: 5.501
Figure 1Speckle tracking profile. The blue myocardial wall segment displays early systolic lengthening and postsystolic shortening. AVC indicates aortic valve closure; SL, strain longitudinal.
Figure 2Schematic drawing of early systolic lengthening. During early systole, the strain curve (blue line) displays early systolic lengthening, as indicated by peak positive systolic strain before the aortic valve closure. Duration of early systolic lengthening is indicated on the curve. The ECG is displayed (orange line).
Figure 3Association between major adverse cardiovascular events (MACEs) and early systolic lengthening. Cubic spline models of the association between MACEs and the early systolic lengthening (ESL) index (A) and ESL duration (B). Black line indicates the unadjusted incidence rate of MACEs, and dotted lines indicate 95% CIs. Histograms display the distribution of the predictor variable in the population.
Baseline Characteristics According to Tertiles of ESL Index
| Characteristics | ESL Index |
| ||
|---|---|---|---|---|
| First Tertile (<5.4%) (n=125) | Second Tertile (5.5%–15.9%) (n=124) | Third Tertile (>16.0%) (n=124) | ||
| Clinical | ||||
| Age, y | 63±11 | 61±12 | 63±11 | 0.701 |
| Men, n (%) | 97 (77.6) | 96 (77.4) | 87 (70.2) | 0.176 |
| Hypertension, n (%) | 40 (32.0) | 39 (31.5) | 40 (32.3) | 0.966 |
| Smoking status, n (%) | 0.940 | |||
| Present | 59 (47.2) | 66 (53.2) | 56 (45.2) | |
| Never | 24 (19.2) | 18 (14.5) | 16 (12.9) | |
| Previous | 32 (25.6) | 34 (27.4) | 38 (30.6) | |
| Mean arterial pressure, mm Hg | 96.7±18.9 | 100.8±18.5 | 101.5±18.3 | 0.044 |
| Heart rate, bpm | 75.1±56.1 | 73.9±14.9 | 79.7±15.5 | 0.304 |
| Diabetes mellitus, n (%) | 10 (8.0) | 10 (8.1) | 12 (9.7) | 0.638 |
| eGFR, mL/min per 1.73 m2 | 73.5 (61.2–87.6) | 73.0 (59.1–85.1) | 73.7 (60.2–86.0) | 0.870 |
| Peak TnI, μg/L | 52 (20–177) | 117 (35–216) | 203 (56–313) | <0.001 |
| Invasive procedure | ||||
| Symptom to balloon, min | 245.0±206.2 | 233.3±177.8 | 280.1±196.7 | 0.155 |
| Location of stenosis, n (%) | <0.001 | |||
| Left anterior descending artery | 46 (37.1) | 55 (44.4) | 77 (62.1) | |
| Right circumflex artery | 64 (51.6) | 53 (42.7) | 36 (29.0) | |
| Left circumflex artery | 14 (11.3) | 16 (12.9) | 11 (8.9) | |
| TIMI flow before PCI, n (%) | <0.001 | |||
| 0–1 | 82 (65.2) | 90 (72.5) | 107 (86.3) | |
| 2–3 | 42 (33.6) | 33 (26.6) | 17 (13.7) | |
| TIMI flow after PCI, n (%) | 0.970 | |||
| 0–1 | 12 (9.6) | 6 (4.8) | 12 (9.7) | |
| 2–3 | 111 (88.8) | 116 (93.5) | 109 (87.9) | |
| Echocardiography | ||||
| LV ejection fraction, % | 47.6±9.1 | 46.5±7.9 | 43.3±9.7 | <0.001 |
| LV mass index, g/m2 | 85.4 (68.9–103.9) | 91.8 (78.2–110.8) | 92.8 (78.0–113.5) | 0.008 |
| Wall motion score index | 1.5±0.4 | 1.5±0.4 | 1.8±0.4 | <0.001 |
| E, cm/s | 8.0±2.1 | 7.7±1.7 | 7.4±1.9 | 0.014 |
| A, cm/s | 7.4±1.8 | 7.5±2.1 | 7.5±2.1 | 0.610 |
| e′, cm/s | 0.8±0.2 | 0.7±0.2 | 0.7±0.2 | <0.001 |
| E/e′ ratio | 10.5±3.9 | 11.2±3.4 | 11.9±5.0 | 0.007 |
| Left atrial volume index, mL/m2 | 25.0±7.1 | 24.9±6.9 | 24.0±6.6 | 0.274 |
| Global longitudinal strain, % | −14.4±3.7 | −12.2±3.1 | −10.5±3.2 | <0.001 |
| Circumferential strain, % | −16.2±5.3 | −16.1±6.2 | −13.1±4.6 | <0.001 |
| Radial strain, % | 32.6±21.4 | 25.4±18.1 | 22.1±14.3 | <0.001 |
| Postsystolic index, % | 8.2 (4.3–18.7) | 15.2 (10.2–22.9) | 27.6 (17.4–41.3) | <0.001 |
| ESL index, % | 2.5 (1.4–3.9) | 8.8 (7.1–11.4) | 41.5 (27.9–77.2) | <0.001 |
| ESL duration, ms | 20.8 (11.0–30.4) | 30.6 (21.6–42.1) | 46.6 (33.5–63.3) | <0.001 |
| Outcome | ||||
| MACE, n (%) | 36 (28.8) | 45 (36.3) | 64 (51.6) | <0.001 |
Data are given as mean±SD, unless otherwise indicated. Nongaussian distributed variables are listed as median (interquartile range). P values were assessed as P for trend by the use of linear regression models and Cuzick's nonparametric test for trend. A, transmitral peak velocity of atrial diastolic filling; bpm, beats per minute; E, transmitral peak velocity of early diastolic filling; e′, average peak early diastolic longitudinal mitral annular velocity; eGFR, estimated glomerular filtration rate; ESL, early systolic lengthening; LV, left ventricular; MACE, major adverse cardiovascular event; PCI, percutaneous coronary intervention; TIMI, Thrombolysis in Myocardial Infarction; TnI, troponin I.
Distribution of the ESL Index and ESL Duration According to Normal, Hypokinetic, and Akinetic Segments, Assessed by Wall Motion Scoring
| Variable | Normal Segments | Hypokinetic Segments | Akinetic Segments |
|---|---|---|---|
| ESL index (%), median (IQR) | 3.2 (1.3–7.8) | 6.0 (1.2–19.0) | 16.6 (3.4–47.7) |
| ESL duration (ms), median (IQR) | 20.3 (10.1–34.9) | 32.2 (12.3–51.0) | 51.3 (29.0–73.8) |
| Postsystolic index (%), median (IQR) | 7.5 (3.9–13.9) | 15.8 (6.9–29.3) | 39.7 (19.7–71.4) |
| Global longitudinal strain (%), median (IQR) | 15.9 (13.5–18.0) | 12.3 (10.0–14.5) | 9.5 (7.0–11.7) |
ESL indicates early systolic lengthening; IQR, interquartile range.
P difference <0.0001 when compared with normal segments.
P difference <0.0001 when compared with hypokinetic segments.
ESL Index and ESL Duration as Predictors of MACEs
| Risk of MACE | ESL Index per 1% Increase, HR (95% CI) |
| ESL Duration per 1‐ms Increase, HR (95% CI) |
|
|---|---|---|---|---|
| Unadjusted | 1.27 (1.13–1.43) | <0.001 | 1.49 (1.15–1.92) | 0.002 |
| C‐statistic, 0.62 | C‐statistic, 0.59 | |||
| Model 1 | 1.29 (1.15–1.44) | <0.001 | 1.47 (1.14–1.89) | 0.003 |
| Model 2 | 1.21 (1.06–1.39) | 0.007 | 1.63 (1.12–2.36) | 0.010 |
ESL indicates early systolic lengthening; HR, hazard ratio; MACE, major adverse cardiovascular event.
Model 1 adjusted for age, sex, hypertension, and heart rate.
Model 2 adjusted for model 1 and TIMI (Thrombolysis in Myocardial Infarction) flow, peak troponin I, left ventricular mass index, left ventricular ejection fraction, ratio between peak transmitral early diastolic inflow velocity and average peak early diastolic mitral annular velocity, wall motion score index, and postsystolic index.
Prognostic Value of the ESL Index and ESL Duration as Predictors of MACEs at 1 Year
| 1‐y Risk of MACEs | ESL Index per 1% Increase, HR (95% CI) |
| ESL Duration per 1‐ms Increase, HR (95% CI) |
|
|---|---|---|---|---|
| Unadjusted | 1.51 (1.26–1.82) | <0.001 | 1.87 (1.22–2.88) | 0.004 |
| C‐statistic, 0.66 | C‐statistic, 0.62 | |||
| Model 1 | 1.51 (1.26–1.82) | <0.001 | 1.96 (1.26–3.04) | 0.003 |
| Model 2 | 1.42 (1.10–1.83) | 0.006 | 2.40 (1.19–4.86) | 0.014 |
ESL indicates early systolic lengthening; HR, hazard ratio; MACE, major adverse cardiovascular event.
Model 1 adjusted for age, sex, hypertension, and heart rate.
Model 2 adjusted for model 1 and TIMI (Thrombolysis in Myocardial Infarction) flow, peak troponin I, left ventricular mass index, left ventricular ejection fraction, ratio between peak transmitral early diastolic inflow velocity and average peak early diastolic mitral annular velocity, wall motion score index, and postsystolic index.
Figure 4Survival curves of the end point, according to tertiles of early systolic lengthening (ESL). Kaplan‐Meier curves displaying the risk of major adverse cardiovascular events (MACEs), according to tertiles of the ESL index (A) and ESL duration (B). Log‐rank values are displayed.